世界の動物用狂犬病ワクチン市場インサイト及び予測(狂犬病ワクチン注射、経口狂犬病ワクチン)

【英語タイトル】Global Veterinary Rabies Vaccine Market Insights, Forecast to 2028

QYResearchが出版した調査資料(QY22DE19454)・商品コード:QY22DE19454
・発行会社(調査会社):QYResearch
・発行日:2022年12月
・ページ数:88
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医薬品&医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥725,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥1,087,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,450,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

COVID-19パンデミックとロシア・ウクライナ戦争の影響により、動物用狂犬病ワクチンの世界市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。
動物用狂犬病ワクチンのアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。
動物用狂犬病ワクチンの中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。
動物用狂犬病ワクチンのヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。

生産面に関しては、当レポートは2017年から2022年までの動物用狂犬病ワクチンの生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面に関しては、当レポートは2017年から2022年までの地域別、企業別、種類別、用途別の動物用狂犬病ワクチンの売上および2028年までの予測に焦点を当てています。

動物用狂犬病ワクチンのグローバル主要企業には、Merck、Zoetis、Boehringer Ingelheim、Ceva、Virbac、Tianjin Ringpu Bio-Technology、Dyntecなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。

動物用狂犬病ワクチン市場は、種類と用途によって区分されます。世界の動物用狂犬病ワクチン市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
狂犬病ワクチン注射、経口狂犬病ワクチン

【用途別セグメント】
愛犬、愛猫、愛玩フェレット、その他

【掲載地域】
北米:アメリカ、カナダ
ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米:メキシコ、ブラジル、アルゼンチン
中東・アフリカ:トルコ、サウジアラビア、UAE

【目次(一部)】

・調査の範囲
- 動物用狂犬病ワクチン製品概要
- 種類別市場(狂犬病ワクチン注射、経口狂犬病ワクチン)
- 用途別市場(愛犬、愛猫、愛玩フェレット、その他)
- 調査の目的
・エグゼクティブサマリー
- 世界の動物用狂犬病ワクチン販売量予測2017-2028
- 世界の動物用狂犬病ワクチン売上予測2017-2028
- 動物用狂犬病ワクチンの地域別販売量
- 動物用狂犬病ワクチンの地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別動物用狂犬病ワクチン販売量
- 主要メーカー別動物用狂犬病ワクチン売上
- 主要メーカー別動物用狂犬病ワクチン価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模(狂犬病ワクチン注射、経口狂犬病ワクチン)
- 動物用狂犬病ワクチンの種類別販売量
- 動物用狂犬病ワクチンの種類別売上
- 動物用狂犬病ワクチンの種類別価格
・用途別市場規模(愛犬、愛猫、愛玩フェレット、その他)
- 動物用狂犬病ワクチンの用途別販売量
- 動物用狂犬病ワクチンの用途別売上
- 動物用狂犬病ワクチンの用途別価格
・北米市場
- 北米の動物用狂犬病ワクチン市場規模(種類別、用途別)
- 主要国別の動物用狂犬病ワクチン市場規模(アメリカ、カナダ)
・ヨーロッパ市場
- ヨーロッパの動物用狂犬病ワクチン市場規模(種類別、用途別)
- 主要国別の動物用狂犬病ワクチン市場規模(ドイツ、フランス、イギリス、イタリア、ロシア)
・アジア太平洋市場
- アジア太平洋の動物用狂犬病ワクチン市場規模(種類別、用途別)
- 主要国別の動物用狂犬病ワクチン市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア)
・中南米市場
- 中南米の動物用狂犬病ワクチン市場規模(種類別、用途別)
- 主要国別の動物用狂犬病ワクチン市場規模(メキシコ、ブラジル、アルゼンチン)
・中東・アフリカ市場
- 中東・アフリカの動物用狂犬病ワクチン市場規模(種類別、用途別)
- 主要国別の動物用狂犬病ワクチン市場規模(トルコ、サウジアラビア)
・企業情報
Merck、Zoetis、Boehringer Ingelheim、Ceva、Virbac、Tianjin Ringpu Bio-Technology、Dyntec
・産業チェーン及び販売チャネル分析
- 動物用狂犬病ワクチンの産業チェーン分析
- 動物用狂犬病ワクチンの原材料
- 動物用狂犬病ワクチンの生産プロセス
- 動物用狂犬病ワクチンの販売及びマーケティング
- 動物用狂犬病ワクチンの主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 動物用狂犬病ワクチンの産業動向
- 動物用狂犬病ワクチンのマーケットドライバー
- 動物用狂犬病ワクチンの課題
- 動物用狂犬病ワクチンの阻害要因
・主な調査結果

Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Veterinary Rabies Vaccine is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Veterinary Rabies Vaccine is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Veterinary Rabies Vaccine is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Veterinary Rabies Vaccine include Merck, Zoetis, Boehringer Ingelheim, Ceva, Virbac, Tianjin Ringpu Bio-Technology and Dyntec, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Veterinary Rabies Vaccine manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Veterinary Rabies Vaccine market. Further, it explains the major drivers and regional dynamics of the global Veterinary Rabies Vaccine market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Merck
Zoetis
Boehringer Ingelheim
Ceva
Virbac
Tianjin Ringpu Bio-Technology
Dyntec
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.
Veterinary Rabies Vaccine Segment by Type
Inject Rabies Vaccine
Oral Rabies Vaccine
Veterinary Rabies Vaccine Segment by Application
Pet Dog
Pet Cat
Pet Ferrets
Oher
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Veterinary Rabies Vaccine market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Veterinary Rabies Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Veterinary Rabies Vaccine, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Veterinary Rabies Vaccine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Veterinary Rabies Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Veterinary Rabies Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Veterinary Rabies Vaccine sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Merck, Zoetis, Boehringer Ingelheim, Ceva, Virbac, Tianjin Ringpu Bio-Technology and Dyntec, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Veterinary Rabies Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Veterinary Rabies Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Veterinary Rabies Vaccine sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Study Coverage
1.1 Veterinary Rabies Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Veterinary Rabies Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Inject Rabies Vaccine
1.2.3 Oral Rabies Vaccine
1.3 Market by Application
1.3.1 Global Veterinary Rabies Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Pet Dog
1.3.3 Pet Cat
1.3.4 Pet Ferrets
1.3.5 Oher
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Veterinary Rabies Vaccine Sales Estimates and Forecasts 2017-2028
2.2 Global Veterinary Rabies Vaccine Revenue Estimates and Forecasts 2017-2028
2.3 Global Veterinary Rabies Vaccine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Veterinary Rabies Vaccine Sales by Region
2.4.1 Global Veterinary Rabies Vaccine Sales by Region (2017-2022)
2.4.2 Global Sales Veterinary Rabies Vaccine by Region (2023-2028)
2.5 Global Veterinary Rabies Vaccine Revenue by Region
2.5.1 Global Veterinary Rabies Vaccine Revenue by Region (2017-2022)
2.5.2 Global Veterinary Rabies Vaccine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Veterinary Rabies Vaccine Sales by Manufacturers
3.1.1 Global Top Veterinary Rabies Vaccine Manufacturers by Sales (2017-2022)
3.1.2 Global Veterinary Rabies Vaccine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Veterinary Rabies Vaccine in 2021
3.2 Global Veterinary Rabies Vaccine Revenue by Manufacturers
3.2.1 Global Veterinary Rabies Vaccine Revenue by Manufacturers (2017-2022)
3.2.2 Global Veterinary Rabies Vaccine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Veterinary Rabies Vaccine Revenue in 2021
3.3 Global Veterinary Rabies Vaccine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Veterinary Rabies Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Veterinary Rabies Vaccine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Veterinary Rabies Vaccine Sales by Type
4.1.1 Global Veterinary Rabies Vaccine Historical Sales by Type (2017-2022)
4.1.2 Global Veterinary Rabies Vaccine Forecasted Sales by Type (2023-2028)
4.1.3 Global Veterinary Rabies Vaccine Sales Market Share by Type (2017-2028)
4.2 Global Veterinary Rabies Vaccine Revenue by Type
4.2.1 Global Veterinary Rabies Vaccine Historical Revenue by Type (2017-2022)
4.2.2 Global Veterinary Rabies Vaccine Forecasted Revenue by Type (2023-2028)
4.2.3 Global Veterinary Rabies Vaccine Revenue Market Share by Type (2017-2028)
4.3 Global Veterinary Rabies Vaccine Price by Type
4.3.1 Global Veterinary Rabies Vaccine Price by Type (2017-2022)
4.3.2 Global Veterinary Rabies Vaccine Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Veterinary Rabies Vaccine Sales by Application
5.1.1 Global Veterinary Rabies Vaccine Historical Sales by Application (2017-2022)
5.1.2 Global Veterinary Rabies Vaccine Forecasted Sales by Application (2023-2028)
5.1.3 Global Veterinary Rabies Vaccine Sales Market Share by Application (2017-2028)
5.2 Global Veterinary Rabies Vaccine Revenue by Application
5.2.1 Global Veterinary Rabies Vaccine Historical Revenue by Application (2017-2022)
5.2.2 Global Veterinary Rabies Vaccine Forecasted Revenue by Application (2023-2028)
5.2.3 Global Veterinary Rabies Vaccine Revenue Market Share by Application (2017-2028)
5.3 Global Veterinary Rabies Vaccine Price by Application
5.3.1 Global Veterinary Rabies Vaccine Price by Application (2017-2022)
5.3.2 Global Veterinary Rabies Vaccine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Veterinary Rabies Vaccine Market Size by Type
6.1.1 North America Veterinary Rabies Vaccine Sales by Type (2017-2028)
6.1.2 North America Veterinary Rabies Vaccine Revenue by Type (2017-2028)
6.2 North America Veterinary Rabies Vaccine Market Size by Application
6.2.1 North America Veterinary Rabies Vaccine Sales by Application (2017-2028)
6.2.2 North America Veterinary Rabies Vaccine Revenue by Application (2017-2028)
6.3 North America Veterinary Rabies Vaccine Market Size by Country
6.3.1 North America Veterinary Rabies Vaccine Sales by Country (2017-2028)
6.3.2 North America Veterinary Rabies Vaccine Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Veterinary Rabies Vaccine Market Size by Type
7.1.1 Europe Veterinary Rabies Vaccine Sales by Type (2017-2028)
7.1.2 Europe Veterinary Rabies Vaccine Revenue by Type (2017-2028)
7.2 Europe Veterinary Rabies Vaccine Market Size by Application
7.2.1 Europe Veterinary Rabies Vaccine Sales by Application (2017-2028)
7.2.2 Europe Veterinary Rabies Vaccine Revenue by Application (2017-2028)
7.3 Europe Veterinary Rabies Vaccine Market Size by Country
7.3.1 Europe Veterinary Rabies Vaccine Sales by Country (2017-2028)
7.3.2 Europe Veterinary Rabies Vaccine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Veterinary Rabies Vaccine Market Size by Type
8.1.1 Asia Pacific Veterinary Rabies Vaccine Sales by Type (2017-2028)
8.1.2 Asia Pacific Veterinary Rabies Vaccine Revenue by Type (2017-2028)
8.2 Asia Pacific Veterinary Rabies Vaccine Market Size by Application
8.2.1 Asia Pacific Veterinary Rabies Vaccine Sales by Application (2017-2028)
8.2.2 Asia Pacific Veterinary Rabies Vaccine Revenue by Application (2017-2028)
8.3 Asia Pacific Veterinary Rabies Vaccine Market Size by Region
8.3.1 Asia Pacific Veterinary Rabies Vaccine Sales by Region (2017-2028)
8.3.2 Asia Pacific Veterinary Rabies Vaccine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Veterinary Rabies Vaccine Market Size by Type
9.1.1 Latin America Veterinary Rabies Vaccine Sales by Type (2017-2028)
9.1.2 Latin America Veterinary Rabies Vaccine Revenue by Type (2017-2028)
9.2 Latin America Veterinary Rabies Vaccine Market Size by Application
9.2.1 Latin America Veterinary Rabies Vaccine Sales by Application (2017-2028)
9.2.2 Latin America Veterinary Rabies Vaccine Revenue by Application (2017-2028)
9.3 Latin America Veterinary Rabies Vaccine Market Size by Country
9.3.1 Latin America Veterinary Rabies Vaccine Sales by Country (2017-2028)
9.3.2 Latin America Veterinary Rabies Vaccine Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Veterinary Rabies Vaccine Market Size by Type
10.1.1 Middle East and Africa Veterinary Rabies Vaccine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Veterinary Rabies Vaccine Revenue by Type (2017-2028)
10.2 Middle East and Africa Veterinary Rabies Vaccine Market Size by Application
10.2.1 Middle East and Africa Veterinary Rabies Vaccine Sales by Application (2017-2028)
10.2.2 Middle East and Africa Veterinary Rabies Vaccine Revenue by Application (2017-2028)
10.3 Middle East and Africa Veterinary Rabies Vaccine Market Size by Country
10.3.1 Middle East and Africa Veterinary Rabies Vaccine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Veterinary Rabies Vaccine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Overview
11.1.3 Merck Veterinary Rabies Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Merck Veterinary Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Merck Recent Developments
11.2 Zoetis
11.2.1 Zoetis Corporation Information
11.2.2 Zoetis Overview
11.2.3 Zoetis Veterinary Rabies Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Zoetis Veterinary Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Zoetis Recent Developments
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Corporation Information
11.3.2 Boehringer Ingelheim Overview
11.3.3 Boehringer Ingelheim Veterinary Rabies Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Boehringer Ingelheim Veterinary Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Boehringer Ingelheim Recent Developments
11.4 Ceva
11.4.1 Ceva Corporation Information
11.4.2 Ceva Overview
11.4.3 Ceva Veterinary Rabies Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Ceva Veterinary Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Ceva Recent Developments
11.5 Virbac
11.5.1 Virbac Corporation Information
11.5.2 Virbac Overview
11.5.3 Virbac Veterinary Rabies Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Virbac Veterinary Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Virbac Recent Developments
11.6 Tianjin Ringpu Bio-Technology
11.6.1 Tianjin Ringpu Bio-Technology Corporation Information
11.6.2 Tianjin Ringpu Bio-Technology Overview
11.6.3 Tianjin Ringpu Bio-Technology Veterinary Rabies Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Tianjin Ringpu Bio-Technology Veterinary Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Tianjin Ringpu Bio-Technology Recent Developments
11.7 Dyntec
11.7.1 Dyntec Corporation Information
11.7.2 Dyntec Overview
11.7.3 Dyntec Veterinary Rabies Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Dyntec Veterinary Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Dyntec Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Veterinary Rabies Vaccine Industry Chain Analysis
12.2 Veterinary Rabies Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Veterinary Rabies Vaccine Production Mode & Process
12.4 Veterinary Rabies Vaccine Sales and Marketing
12.4.1 Veterinary Rabies Vaccine Sales Channels
12.4.2 Veterinary Rabies Vaccine Distributors
12.5 Veterinary Rabies Vaccine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Veterinary Rabies Vaccine Industry Trends
13.2 Veterinary Rabies Vaccine Market Drivers
13.3 Veterinary Rabies Vaccine Market Challenges
13.4 Veterinary Rabies Vaccine Market Restraints
14 Key Findings in The Global Veterinary Rabies Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Veterinary Rabies Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Inject Rabies Vaccine
Table 3. Major Manufacturers of Oral Rabies Vaccine
Table 4. Global Veterinary Rabies Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Veterinary Rabies Vaccine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Veterinary Rabies Vaccine Sales by Region (2017-2022) & (M Doses)
Table 7. Global Veterinary Rabies Vaccine Sales Market Share by Region (2017-2022)
Table 8. Global Veterinary Rabies Vaccine Sales by Region (2023-2028) & (M Doses)
Table 9. Global Veterinary Rabies Vaccine Sales Market Share by Region (2023-2028)
Table 10. Global Veterinary Rabies Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Veterinary Rabies Vaccine Revenue Market Share by Region (2017-2022)
Table 12. Global Veterinary Rabies Vaccine Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Veterinary Rabies Vaccine Revenue Market Share by Region (2023-2028)
Table 14. Global Veterinary Rabies Vaccine Sales by Manufacturers (2017-2022) & (M Doses)
Table 15. Global Veterinary Rabies Vaccine Sales Share by Manufacturers (2017-2022)
Table 16. Global Veterinary Rabies Vaccine Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Veterinary Rabies Vaccine Revenue Share by Manufacturers (2017-2022)
Table 18. Veterinary Rabies Vaccine Price by Manufacturers (2017-2022) &(US$/K Doses)
Table 19. Global Veterinary Rabies Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Veterinary Rabies Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Rabies Vaccine as of 2021)
Table 21. Veterinary Rabies Vaccine Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Veterinary Rabies Vaccine Product Offered
Table 23. Date of Manufacturers Enter into Veterinary Rabies Vaccine Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Veterinary Rabies Vaccine Sales by Type (2017-2022) & (M Doses)
Table 26. Global Veterinary Rabies Vaccine Sales by Type (2023-2028) & (M Doses)
Table 27. Global Veterinary Rabies Vaccine Sales Share by Type (2017-2022)
Table 28. Global Veterinary Rabies Vaccine Sales Share by Type (2023-2028)
Table 29. Global Veterinary Rabies Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Veterinary Rabies Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Veterinary Rabies Vaccine Revenue Share by Type (2017-2022)
Table 32. Global Veterinary Rabies Vaccine Revenue Share by Type (2023-2028)
Table 33. Veterinary Rabies Vaccine Price by Type (2017-2022) & (US$/K Doses)
Table 34. Global Veterinary Rabies Vaccine Price Forecast by Type (2023-2028) & (US$/K Doses)
Table 35. Global Veterinary Rabies Vaccine Sales by Application (2017-2022) & (M Doses)
Table 36. Global Veterinary Rabies Vaccine Sales by Application (2023-2028) & (M Doses)
Table 37. Global Veterinary Rabies Vaccine Sales Share by Application (2017-2022)
Table 38. Global Veterinary Rabies Vaccine Sales Share by Application (2023-2028)
Table 39. Global Veterinary Rabies Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Veterinary Rabies Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Veterinary Rabies Vaccine Revenue Share by Application (2017-2022)
Table 42. Global Veterinary Rabies Vaccine Revenue Share by Application (2023-2028)
Table 43. Veterinary Rabies Vaccine Price by Application (2017-2022) & (US$/K Doses)
Table 44. Global Veterinary Rabies Vaccine Price Forecast by Application (2023-2028) & (US$/K Doses)
Table 45. North America Veterinary Rabies Vaccine Sales by Type (2017-2022) & (M Doses)
Table 46. North America Veterinary Rabies Vaccine Sales by Type (2023-2028) & (M Doses)
Table 47. North America Veterinary Rabies Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Veterinary Rabies Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Veterinary Rabies Vaccine Sales by Application (2017-2022) & (M Doses)
Table 50. North America Veterinary Rabies Vaccine Sales by Application (2023-2028) & (M Doses)
Table 51. North America Veterinary Rabies Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Veterinary Rabies Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Veterinary Rabies Vaccine Sales by Country (2017-2022) & (M Doses)
Table 54. North America Veterinary Rabies Vaccine Sales by Country (2023-2028) & (M Doses)
Table 55. North America Veterinary Rabies Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Veterinary Rabies Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Veterinary Rabies Vaccine Sales by Type (2017-2022) & (M Doses)
Table 58. Europe Veterinary Rabies Vaccine Sales by Type (2023-2028) & (M Doses)
Table 59. Europe Veterinary Rabies Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Veterinary Rabies Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Veterinary Rabies Vaccine Sales by Application (2017-2022) & (M Doses)
Table 62. Europe Veterinary Rabies Vaccine Sales by Application (2023-2028) & (M Doses)
Table 63. Europe Veterinary Rabies Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Veterinary Rabies Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Veterinary Rabies Vaccine Sales by Country (2017-2022) & (M Doses)
Table 66. Europe Veterinary Rabies Vaccine Sales by Country (2023-2028) & (M Doses)
Table 67. Europe Veterinary Rabies Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Veterinary Rabies Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Veterinary Rabies Vaccine Sales by Type (2017-2022) & (M Doses)
Table 70. Asia Pacific Veterinary Rabies Vaccine Sales by Type (2023-2028) & (M Doses)
Table 71. Asia Pacific Veterinary Rabies Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Veterinary Rabies Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Veterinary Rabies Vaccine Sales by Application (2017-2022) & (M Doses)
Table 74. Asia Pacific Veterinary Rabies Vaccine Sales by Application (2023-2028) & (M Doses)
Table 75. Asia Pacific Veterinary Rabies Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Veterinary Rabies Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Veterinary Rabies Vaccine Sales by Region (2017-2022) & (M Doses)
Table 78. Asia Pacific Veterinary Rabies Vaccine Sales by Region (2023-2028) & (M Doses)
Table 79. Asia Pacific Veterinary Rabies Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Veterinary Rabies Vaccine Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Veterinary Rabies Vaccine Sales by Type (2017-2022) & (M Doses)
Table 82. Latin America Veterinary Rabies Vaccine Sales by Type (2023-2028) & (M Doses)
Table 83. Latin America Veterinary Rabies Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Veterinary Rabies Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Veterinary Rabies Vaccine Sales by Application (2017-2022) & (M Doses)
Table 86. Latin America Veterinary Rabies Vaccine Sales by Application (2023-2028) & (M Doses)
Table 87. Latin America Veterinary Rabies Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Veterinary Rabies Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Veterinary Rabies Vaccine Sales by Country (2017-2022) & (M Doses)
Table 90. Latin America Veterinary Rabies Vaccine Sales by Country (2023-2028) & (M Doses)
Table 91. Latin America Veterinary Rabies Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Veterinary Rabies Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Veterinary Rabies Vaccine Sales by Type (2017-2022) & (M Doses)
Table 94. Middle East and Africa Veterinary Rabies Vaccine Sales by Type (2023-2028) & (M Doses)
Table 95. Middle East and Africa Veterinary Rabies Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Veterinary Rabies Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Veterinary Rabies Vaccine Sales by Application (2017-2022) & (M Doses)
Table 98. Middle East and Africa Veterinary Rabies Vaccine Sales by Application (2023-2028) & (M Doses)
Table 99. Middle East and Africa Veterinary Rabies Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Veterinary Rabies Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Veterinary Rabies Vaccine Sales by Country (2017-2022) & (M Doses)
Table 102. Middle East and Africa Veterinary Rabies Vaccine Sales by Country (2023-2028) & (M Doses)
Table 103. Middle East and Africa Veterinary Rabies Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Veterinary Rabies Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 105. Merck Corporation Information
Table 106. Merck Description and Major Businesses
Table 107. Merck Veterinary Rabies Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2017-2022)
Table 108. Merck Veterinary Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Merck Recent Developments
Table 110. Zoetis Corporation Information
Table 111. Zoetis Description and Major Businesses
Table 112. Zoetis Veterinary Rabies Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2017-2022)
Table 113. Zoetis Veterinary Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Zoetis Recent Developments
Table 115. Boehringer Ingelheim Corporation Information
Table 116. Boehringer Ingelheim Description and Major Businesses
Table 117. Boehringer Ingelheim Veterinary Rabies Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2017-2022)
Table 118. Boehringer Ingelheim Veterinary Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Boehringer Ingelheim Recent Developments
Table 120. Ceva Corporation Information
Table 121. Ceva Description and Major Businesses
Table 122. Ceva Veterinary Rabies Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2017-2022)
Table 123. Ceva Veterinary Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Ceva Recent Developments
Table 125. Virbac Corporation Information
Table 126. Virbac Description and Major Businesses
Table 127. Virbac Veterinary Rabies Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2017-2022)
Table 128. Virbac Veterinary Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Virbac Recent Developments
Table 130. Tianjin Ringpu Bio-Technology Corporation Information
Table 131. Tianjin Ringpu Bio-Technology Description and Major Businesses
Table 132. Tianjin Ringpu Bio-Technology Veterinary Rabies Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2017-2022)
Table 133. Tianjin Ringpu Bio-Technology Veterinary Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Tianjin Ringpu Bio-Technology Recent Developments
Table 135. Dyntec Corporation Information
Table 136. Dyntec Description and Major Businesses
Table 137. Dyntec Veterinary Rabies Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2017-2022)
Table 138. Dyntec Veterinary Rabies Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Dyntec Recent Developments
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Veterinary Rabies Vaccine Distributors List
Table 143. Veterinary Rabies Vaccine Customers List
Table 144. Veterinary Rabies Vaccine Market Trends
Table 145. Veterinary Rabies Vaccine Market Drivers
Table 146. Veterinary Rabies Vaccine Market Challenges
Table 147. Veterinary Rabies Vaccine Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Veterinary Rabies Vaccine Product Picture
Figure 2. Global Veterinary Rabies Vaccine Market Share by Type in 2021 & 2028
Figure 3. Inject Rabies Vaccine Product Picture
Figure 4. Oral Rabies Vaccine Product Picture
Figure 5. Global Veterinary Rabies Vaccine Market Share by Application in 2021 & 2028
Figure 6. Pet Dog
Figure 7. Pet Cat
Figure 8. Pet Ferrets
Figure 9. Oher
Figure 10. Veterinary Rabies Vaccine Report Years Considered
Figure 11. Global Veterinary Rabies Vaccine Sales 2017-2028 (M Doses)
Figure 12. Global Veterinary Rabies Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Veterinary Rabies Vaccine Revenue 2017-2028 (US$ Million)
Figure 14. Global Veterinary Rabies Vaccine Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global Veterinary Rabies Vaccine Sales Market Share by Region (2017-2022)
Figure 16. Global Veterinary Rabies Vaccine Sales Market Share by Region (2023-2028)
Figure 17. North America Veterinary Rabies Vaccine Sales YoY (2017-2028) & (M Doses)
Figure 18. North America Veterinary Rabies Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Europe Veterinary Rabies Vaccine Sales YoY (2017-2028) & (M Doses)
Figure 20. Europe Veterinary Rabies Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Asia-Pacific Veterinary Rabies Vaccine Sales YoY (2017-2028) & (M Doses)
Figure 22. Asia-Pacific Veterinary Rabies Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Latin America Veterinary Rabies Vaccine Sales YoY (2017-2028) & (M Doses)
Figure 24. Latin America Veterinary Rabies Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Middle East & Africa Veterinary Rabies Vaccine Sales YoY (2017-2028) & (M Doses)
Figure 26. Middle East & Africa Veterinary Rabies Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 27. The Veterinary Rabies Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 28. The Top 5 and 10 Largest Manufacturers of Veterinary Rabies Vaccine in the World: Market Share by Veterinary Rabies Vaccine Revenue in 2021
Figure 29. Global Veterinary Rabies Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 30. Global Veterinary Rabies Vaccine Sales Market Share by Type (2017-2028)
Figure 31. Global Veterinary Rabies Vaccine Revenue Market Share by Type (2017-2028)
Figure 32. Global Veterinary Rabies Vaccine Sales Market Share by Application (2017-2028)
Figure 33. Global Veterinary Rabies Vaccine Revenue Market Share by Application (2017-2028)
Figure 34. North America Veterinary Rabies Vaccine Sales Market Share by Type (2017-2028)
Figure 35. North America Veterinary Rabies Vaccine Revenue Market Share by Type (2017-2028)
Figure 36. North America Veterinary Rabies Vaccine Sales Market Share by Application (2017-2028)
Figure 37. North America Veterinary Rabies Vaccine Revenue Market Share by Application (2017-2028)
Figure 38. North America Veterinary Rabies Vaccine Sales Share by Country (2017-2028)
Figure 39. North America Veterinary Rabies Vaccine Revenue Share by Country (2017-2028)
Figure 40. United States Veterinary Rabies Vaccine Revenue (2017-2028) & (US$ Million)
Figure 41. Canada Veterinary Rabies Vaccine Revenue (2017-2028) & (US$ Million)
Figure 42. Europe Veterinary Rabies Vaccine Sales Market Share by Type (2017-2028)
Figure 43. Europe Veterinary Rabies Vaccine Revenue Market Share by Type (2017-2028)
Figure 44. Europe Veterinary Rabies Vaccine Sales Market Share by Application (2017-2028)
Figure 45. Europe Veterinary Rabies Vaccine Revenue Market Share by Application (2017-2028)
Figure 46. Europe Veterinary Rabies Vaccine Sales Share by Country (2017-2028)
Figure 47. Europe Veterinary Rabies Vaccine Revenue Share by Country (2017-2028)
Figure 48. Germany Veterinary Rabies Vaccine Revenue (2017-2028) & (US$ Million)
Figure 49. France Veterinary Rabies Vaccine Revenue (2017-2028) & (US$ Million)
Figure 50. U.K. Veterinary Rabies Vaccine Revenue (2017-2028) & (US$ Million)
Figure 51. Italy Veterinary Rabies Vaccine Revenue (2017-2028) & (US$ Million)
Figure 52. Russia Veterinary Rabies Vaccine Revenue (2017-2028) & (US$ Million)
Figure 53. Asia Pacific Veterinary Rabies Vaccine Sales Market Share by Type (2017-2028)
Figure 54. Asia Pacific Veterinary Rabies Vaccine Revenue Market Share by Type (2017-2028)
Figure 55. Asia Pacific Veterinary Rabies Vaccine Sales Market Share by Application (2017-2028)
Figure 56. Asia Pacific Veterinary Rabies Vaccine Revenue Market Share by Application (2017-2028)
Figure 57. Asia Pacific Veterinary Rabies Vaccine Sales Share by Region (2017-2028)
Figure 58. Asia Pacific Veterinary Rabies Vaccine Revenue Share by Region (2017-2028)
Figure 59. China Veterinary Rabies Vaccine Revenue (2017-2028) & (US$ Million)
Figure 60. Japan Veterinary Rabies Vaccine Revenue (2017-2028) & (US$ Million)
Figure 61. South Korea Veterinary Rabies Vaccine Revenue (2017-2028) & (US$ Million)
Figure 62. India Veterinary Rabies Vaccine Revenue (2017-2028) & (US$ Million)
Figure 63. Australia Veterinary Rabies Vaccine Revenue (2017-2028) & (US$ Million)
Figure 64. China Taiwan Veterinary Rabies Vaccine Revenue (2017-2028) & (US$ Million)
Figure 65. Indonesia Veterinary Rabies Vaccine Revenue (2017-2028) & (US$ Million)
Figure 66. Thailand Veterinary Rabies Vaccine Revenue (2017-2028) & (US$ Million)
Figure 67. Malaysia Veterinary Rabies Vaccine Revenue (2017-2028) & (US$ Million)
Figure 68. Latin America Veterinary Rabies Vaccine Sales Market Share by Type (2017-2028)
Figure 69. Latin America Veterinary Rabies Vaccine Revenue Market Share by Type (2017-2028)
Figure 70. Latin America Veterinary Rabies Vaccine Sales Market Share by Application (2017-2028)
Figure 71. Latin America Veterinary Rabies Vaccine Revenue Market Share by Application (2017-2028)
Figure 72. Latin America Veterinary Rabies Vaccine Sales Share by Country (2017-2028)
Figure 73. Latin America Veterinary Rabies Vaccine Revenue Share by Country (2017-2028)
Figure 74. Mexico Veterinary Rabies Vaccine Revenue (2017-2028) & (US$ Million)
Figure 75. Brazil Veterinary Rabies Vaccine Revenue (2017-2028) & (US$ Million)
Figure 76. Argentina Veterinary Rabies Vaccine Revenue (2017-2028) & (US$ Million)
Figure 77. Colombia Veterinary Rabies Vaccine Revenue (2017-2028) & (US$ Million)
Figure 78. Middle East and Africa Veterinary Rabies Vaccine Sales Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Veterinary Rabies Vaccine Revenue Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Veterinary Rabies Vaccine Sales Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Veterinary Rabies Vaccine Revenue Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Veterinary Rabies Vaccine Sales Share by Country (2017-2028)
Figure 83. Middle East and Africa Veterinary Rabies Vaccine Revenue Share by Country (2017-2028)
Figure 84. Turkey Veterinary Rabies Vaccine Revenue (2017-2028) & (US$ Million)
Figure 85. Saudi Arabia Veterinary Rabies Vaccine Revenue (2017-2028) & (US$ Million)
Figure 86. UAE Veterinary Rabies Vaccine Revenue (2017-2028) & (US$ Million)
Figure 87. Veterinary Rabies Vaccine Value Chain
Figure 88. Veterinary Rabies Vaccine Production Process
Figure 89. Channels of Distribution
Figure 90. Distributors Profiles
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed


★調査レポート[世界の動物用狂犬病ワクチン市場インサイト及び予測(狂犬病ワクチン注射、経口狂犬病ワクチン)] (コード:QY22DE19454)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の動物用狂犬病ワクチン市場インサイト及び予測(狂犬病ワクチン注射、経口狂犬病ワクチン)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆